The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in income, its patent expiration created a wave of lower-priced alternatives , significantly impacting its position . While specific firms may try to capitalize on male sexual dysfunction, the exi… Read More